A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...

CAMBRIDGE, Mass., March 28, 2026--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) ...

Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.

Please provide your email address to receive an email when new articles are posted on . At diagnosis, the area under the receiver operating characteristic curve in two test sets was 0.92 and 0.88.

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...

A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented serious disease or death for thousands of ...

Add Yahoo as a preferred source to see more of our stories on Google. PH is a progressive pulmonary vascular disease estimated to affect up to 1% of the global population. Credit: Orawan ...

* The Apple Watch's new HTNF algorithm now has FDA clearance to issue notifications when it detects patterns suggestive of hypertension * Over a 30-day monitoring period, it uses optical sensor //data ...